Sort
40,608 grants matching “prostate cancer”
The BRCA Exchange Knowledgebase for Clinical Cancer Genetics
$660,079Melissa Suzanne Cline · University Of California Santa Cruz · U24 · FY2025 · CA
GP 140/CDCPI IN THE DEVELOPMENT OF PROSTATE CANCER METASTASIS
$660,000Cedars-Sinai Medical Center · · FY2008 · Department of the Army
DEVELOPMENT OF PRECISION IMMUNOTHERAPY FOR ADVANCED PROSTATE CANCER
$659,999Fred Hutchinson Cancer Research Center · · FY2015 · Department of Defense
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
$659,732Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2022 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$659,547Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment
$659,542Matthew R Cooperberg · University Of California, San Francisco · R01 · FY2016 · CA
Racial Disparities in the Mechanisms of Prostate Cancer Metastasis
$659,498Carlos S Moreno · Emory University · R01 · FY2025 · CA
Genomic Enhancers at 8q24 and Prostate Cancer
$659,462Gerhard A Coetzee · University Of Southern California · R01 · FY2010 · CA
MOLECULAR RECLASSIFICATION OF PROSTATIC CANCER
$659,364University Of Pittsburgh At Pittsburgh · U01 · FY2003 · CA
Hormones and Cytokines in CaP risk and recurrence
$659,291Brigham And Women'S Hospital · R01 · FY2005 · CA
MICRORNA PREDICTORS OF PROSTATE CANCER OUTCOME IN AFRICAN-AMERICAN MEN
$659,249Henry Ford Health System · · FY2010 · Department of the Army
Platelets in Cancer
$659,214Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL
Platelets in Cancer
$659,214Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
DEVELOPMENT OF PRECISION IMMUNOTHERAPY FOR ADVANCED PROSTATE CANCER
$659,099Fred Hutchinson Cancer Research Center · · FY2015 · Department of Defense
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:
$658,881Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer
$658,872David B Agus · Stanford University · U54 · FY2006 · CA
A transdisciplinary approach for dissecting stem cell states in prostate cancer
$658,850Raul Rabadan · Columbia University Health Sciences · U01 · FY2022 · CA
BIOMARKER DISCOVERY AND MECHANISTIC STUDIES OF PROSTATE CANCER USING TARGETED PROTEOMIC APPROACHES
$658,827University Of Kentucky Research Foundation, The · · FY2008 · Department of Defense
CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS
$658,770Fundacio Privada Institut D Investigacio Oncologica De Vall-Hebron · · FY2018 · Defense Health Agency
Integrating Epigenetic Modulation into DNA Damage Repair
$658,646Pamela N Munster · University Of California, San Francisco · R01 · FY2025 · CA
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
$658,627Iwao Ojima · State University New York Stony Brook · R01 · FY2022 · CA
Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention
$658,509Jeffrey Kuang Zou Lee · Kaiser Foundation Research Institute · R37 · FY2024 · CA
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
$658,228Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2023 · CA
NOVEL INHIBITORS OF PROTEIN-PROTEIN INTERACTION FOR PROSTATE CANCER THERAPY
$658,155University Of Wisconsin System · · FY2010 · Department of the Army
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
$658,057Hiroaki Matsunami · Duke University · R01 · FY2023 · DC